Ice steam Rus (MOEX:SIBG)
Russia · Delayed Price · Currency is RUB 0.0490
-0.0005 (-1.01%)
At close: Jul 8, 2022
Revance Therapeutics Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '21 Jun 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2016 |
| 24.72 | 29.99 | 32.76 | 7.71 | - | 0.66 | Upgrade | |
Revenue Growth (YoY) | -28.73% | -8.44% | 324.74% | - | - | -80.92% | Upgrade |
Cost of Revenue | 21.35 | 19.05 | 24.5 | 10.12 | - | 0.55 | Upgrade |
Gross Profit | 3.38 | 10.94 | 8.25 | -2.41 | - | 0.11 | Upgrade |
Selling, General & Admin | 14.38 | 16.9 | 16.86 | 15.27 | 37.48 | 37.55 | Upgrade |
Operating Expenses | 14.38 | 16.9 | 16.86 | 22.32 | 37.48 | 37.55 | Upgrade |
Operating Income | -11.01 | -5.96 | -8.61 | -24.72 | -37.48 | -37.44 | Upgrade |
Interest Expense | -0.41 | -3.5 | -15.79 | - | - | - | Upgrade |
Interest & Investment Income | - | - | 15.59 | 8.87 | 4.93 | - | Upgrade |
Currency Exchange Gain (Loss) | -10.59 | -10.59 | - | -29.6 | 0.07 | - | Upgrade |
Other Non Operating Income (Expenses) | 7.18 | 6.37 | -17.73 | -60.34 | -12.08 | -17.45 | Upgrade |
EBT Excluding Unusual Items | -14.83 | -13.68 | -26.54 | -105.8 | -44.57 | -54.89 | Upgrade |
Gain (Loss) on Sale of Assets | 1.11 | 1.11 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | -0.03 | Upgrade |
Pretax Income | -13.72 | -12.57 | -26.54 | -105.8 | -44.57 | -54.92 | Upgrade |
Income Tax Expense | -0.03 | - | - | 1.38 | -1.37 | - | Upgrade |
Net Income | -13.69 | -12.57 | -26.54 | -107.18 | -43.2 | -54.92 | Upgrade |
Net Income to Common | -13.69 | -12.57 | -26.54 | -107.18 | -43.2 | -54.92 | Upgrade |
Shares Outstanding (Basic) | 600 | 633 | 92 | 100 | - | - | Upgrade |
Shares Outstanding (Diluted) | 600 | 633 | 92 | 100 | - | - | Upgrade |
Shares Change (YoY) | 500.00% | 592.03% | -8.48% | - | - | - | Upgrade |
EPS (Basic) | -0.02 | -0.02 | -0.29 | -1.07 | - | - | Upgrade |
EPS (Diluted) | -0.02 | -0.02 | -0.29 | -1.07 | - | - | Upgrade |
Free Cash Flow | - | - | 0.97 | -19.11 | -90.34 | -59.92 | Upgrade |
Free Cash Flow Per Share | - | - | 0.01 | -0.19 | - | - | Upgrade |
Gross Margin | 13.66% | 36.47% | 25.19% | -31.19% | - | 16.26% | Upgrade |
Operating Margin | -44.52% | -19.88% | -26.28% | -320.56% | - | -5689.82% | Upgrade |
Profit Margin | -55.37% | -41.91% | -81.02% | -1389.80% | - | -8346.05% | Upgrade |
Free Cash Flow Margin | - | - | 2.97% | -247.76% | - | -9105.77% | Upgrade |
EBITDA | 2.33 | 7.16 | 4.09 | -17.68 | -8.28 | -8.34 | Upgrade |
EBITDA Margin | 9.41% | 23.87% | 12.47% | -229.21% | - | - | Upgrade |
D&A For EBITDA | 13.33 | 13.12 | 12.69 | 7.05 | 29.2 | 29.1 | Upgrade |
EBIT | -11.01 | -5.96 | -8.61 | -24.72 | -37.48 | -37.44 | Upgrade |
EBIT Margin | -44.52% | -19.88% | -26.28% | - | - | - | Upgrade |
Revenue as Reported | - | - | - | 7.71 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.